Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 ...

The Trump administration is indefinitely delaying a Medicare pilot program to cover weight-loss drugs after health insurance ...

Meanwhile — in a late-breaking moment — federal officials are having to pivot on the fly after insurers panned the effort to ...

The federal government scrapped a plan to have health insurance companies fund coverage of obesity drugs for seniors, opting instead to pay for the medicine with taxpayer dollars through the ...

Two of the biggest insurance providers have expressed reluctance to participate in the government’s BALANCE program that ...

Some health insurers are pushing back against a new program that will allow Medicare beneficiaries to pay $50 per month for ...

Eli Lilly (LLY) stock and Novo Nordisk (NONOF) stock are in focus as Medicare extends interim coverage for GLP-1 weight loss ...

Insurance coverage for GLP-1 medications like Ozempic and Wegovy varies widely depending on the condition and your plan.

What Are GLP-1 Drugs? Injectable GLP-1 (glucagon-like peptide-1) receptor agonists were first introduced for managing Type 2 diabetes, a condition that affects over a quarter of Medicare beneficiaries ...

By adding digital health and nutrition support to Rx access, the retailer hopes to win share with the weight-loss army.

Retailers race into GLP-1 market as Amazon and Walmart expand weight management programs, reshaping access and care delivery in obesity treatment.

Health insurers are raising questions about the Trump administration’s plan to cover obesity drugs in Medicare next year, casting doubt on whether enough insurers will sign on to the effort for it to ...